Overview
Kell isoimmunization in pregnancy occurs when maternal antibodies target fetal red blood cells expressing the Kell antigen, leading to hemolytic disease of the newborn (HDFN) characterized by fetal or neonatal anemia 1.Diagnosis
Routine antenatal screening for maternal blood group and antibodies, including anti-Kell 1.
Fetal anemia assessment via Doppler ultrasound or middle cerebral artery peak systolic velocity (MCA PSV) 1.
Confirmatory cord blood sampling postnatally to measure bilirubin levels and hematocrit 1.Management
First-line: Intrauterine transfusion for severe cases of fetal anemia 1.
Adjunctive: Postnatal management includes phototherapy for hyperbilirubinemia and exchange transfusion if necessary 1.
Prophylactic measures: Rh immunoglobulin administration is specific to Rh incompatibility; similar strategies for Kell isoimmunization are less standardized but may include close monitoring and supportive care 1.Special Populations
Pregnancy: Close monitoring and timely intervention are crucial for managing Kell isoimmunized pregnancies to prevent severe fetal anemia 1.
Pediatrics: Neonates require vigilant observation for signs of anemia and jaundice, necessitating prompt treatment 1.Key Recommendations
Routinely screen pregnant women for all relevant red blood cell antibodies, including anti-Kell, to identify at-risk pregnancies (Evidence: Moderate 1).
Implement close fetal monitoring with Doppler ultrasound and MCA PSV for detecting anemia in Kell isoimmunized fetuses (Evidence: Moderate 1).
Provide intrauterine transfusions for severe cases of fetal anemia identified in Kell isoimmunized pregnancies (Evidence: Expert opinion 1).
Ensure postnatal care includes monitoring for hyperbilirubinemia and readiness for exchange transfusion if indicated (Evidence: Expert opinion 1).References
1 Cordell V, Soe A, Latham T, Bills VL. The Use of Novel Therapies in the Management of Haemolytic Disease of the Fetus and Newborn (HDFN): Scientific Impact Paper No. 75. BJOG : an international journal of obstetrics and gynaecology 2025. link
2 Slootweg YM, Walg C, Koelewijn JM, Van Kamp IL, De Haas M. Knowledge, attitude and practices of obstetric care providers towards maternal red-blood-cell immunization during pregnancy. Vox sanguinis 2020. link